41 studies found for:    "Diabetes Insipidus" [DISEASE]
Show Display Options
Rank Status Study
21 Completed Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion;   Hyponatremia
Intervention: Drug: satavaptan (SR121463B)
22 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
23 Completed
Has Results
V2 Receptor Effects on Fluid Regulation and Performance
Conditions: Electrolyte Imbalance;   Hyponatremia;   Hypernatremia
Intervention: Drug: V2R (Vasopressin 2 receptor)
24 Unknown  Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
25 Recruiting Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome
Conditions: Healthy;   Polyuria-polydipsia Syndrome
Intervention:
26 Not yet recruiting A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
Intervention: Drug: dantrolene sodium
27 Unknown  GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
28 Completed Hemodynamic Effects of Vasopressin in Early Septic Shock Stage
Condition: Septic Shock
Intervention: Drug: Vasopressin infusion
29 Completed Desmopressin in Cardiac Surgery
Conditions: Hemorrhage;   Blood Loss, Surgical;   Postoperative Hemorrhage
Interventions: Drug: Desmopressin (DDAVP);   Drug: Placebo
30 Completed Vasopressin in Traumatic Hemorrhagic Shock Study
Conditions: Shock;   Hypovolemia;   Hemorrhagic Shock
Interventions: Drug: Vasopressin;   Drug: Saline placebo
31 Terminated A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Conditions: Hyponatremia;   Inappropriate ADH Syndrome
Interventions: Drug: Satavaptan;   Drug: placebo
32 Completed Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
Condition: Pituitary Adenoma
Intervention:
33 Completed Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury
Conditions: Electrolyte Disturbances;   Subarachnoid Hemorrhage;   Traumatic Brain Injury;   Natriuretic Peptides
Intervention:
34 Completed Copeptin in Differentiation of Polyuria and Polydipsia
Conditions: Polyuria;   Polydipsia
Intervention:
35 Completed The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)
Conditions: Stroke;   Transient Ischemic Attack
Intervention:
36 Unknown  Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
Conditions: Hyponatremia;   Ascites
Interventions: Drug: Tolvaptan;   Drug: placebo
37 Completed Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
38 Recruiting
Has Results
Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
Conditions: Hypertension;   End Stage Renal Disease
Interventions: Drug: Vasopressin - Very Low Dose;   Drug: Vasopressin - Low Dose;   Drug: Placebo Comparator
39 Suspended Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Intervention:
40 Active, not recruiting Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis
Conditions: Acute Pancreatitis;   Pancreatitis
Intervention: Other: No intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years